89bio, Inc.

CIK 1785173 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for 89bio, Inc..

Recent SEC filings

FiledFormAccession number
Feb 13, 2026SCHEDULE 13G/A0001172661-26-000712
Nov 19, 2025EFFECT9999999995-25-003316
Nov 14, 2025SCHEDULE 13G/A0001172661-25-004825
Nov 14, 2025SCHEDULE 13G0000902664-25-005057
Nov 13, 2025SCHEDULE 13G/A0000919574-25-006756
Nov 3, 2025SCHEDULE 13D/A0001346824-25-000037
Nov 3, 202540001231919-25-000402
Oct 31, 2025SCHEDULE 13D/A0000902664-25-004684
Oct 30, 202540001193125-25-259037
Oct 30, 202540001193125-25-259034
Oct 30, 202540001193125-25-259064
Oct 30, 2025S-8 POS0001193125-25-258698
Oct 30, 2025S-8 POS0001193125-25-258707
Oct 30, 2025POSASR0001193125-25-258731
Oct 30, 2025S-8 POS0001193125-25-258713
Oct 30, 2025POS AM0001193125-25-258723
Oct 30, 20258-K0001193125-25-257616
Oct 30, 202540001193125-25-259069
Oct 30, 202540001193125-25-259054
Oct 30, 2025POSASR0001193125-25-258734
Oct 30, 202525-NSE0001354457-25-001073
Oct 30, 2025S-8 POS0001193125-25-258676
Oct 30, 2025SC TO-T/A0001193125-25-257567
Oct 30, 2025SC 14D9/A0001193125-25-257605
Oct 30, 2025S-8 POS0001193125-25-258689